Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000347783

Medchemexpress LLC Camonsertib | 2417489-10-0 | 99.99% | 410.47 | 100 MG
SDP

Catalog No. 5000347783
Encompass_Preferred

Camonsertib (RP-3500) is an orally active, selective ATR kinase inhibitor (ATRi) with an IC50 of 1.00 nM in biochemical assays. It demonstrates 30-fold selectivity for ATR over mTOR (IC50=120 nM) and >2,000-fold selectivity over ATM, DNA-PK, and PI3Kα kinases. Camonsertib exhibits potent antitumor activity.

  • Orally active, selective ATR kinase inhibitor
  • IC50 of 1.00 nM for ATR in biochemical assays
  • Exhibits 30-fold selectivity for ATR over mTOR
  • Shows >2,000-fold selectivity over ATM, DNA-PK, and PI3Kα kinases
  • Demonstrates potent antitumor activity

Catalog No. 50-003-47783 Supplier Medchemexpress LLC Supplier No. HY139609100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Camonsertib (RP-3500) is an orally active, selective ATR kinase inhibitor (ATRi) with an IC50 of 1.00 nM in biochemical assays. It demonstrates 30-fold selectivity for ATR over mTOR (IC50=120 nM) and >2,000-fold selectivity over ATM, DNA-PK, and PI3Kα kinases. Camonsertib exhibits potent antitumor activity.

  • Orally active, selective ATR kinase inhibitor
  • IC50 of 1.00 nM for ATR in biochemical assays
  • Exhibits 30-fold selectivity for ATR over mTOR
  • Shows >2,000-fold selectivity over ATM, DNA-PK, and PI3Kα kinases
  • Demonstrates potent antitumor activity

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.